Related Experiment Video For breast tumours
Updated: Nov 1, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?
Dan Chaltiel1,2, Catherine Hill3
1Bureau de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France dan.chaltiel@gustaveroussy.fr.
Background:
Published estimations of the extent of breast cancer overdiagnosis vary widely, and there have been heated debates around these estimations. Some high estimates have even been the basis of campaigns against national breast cancer screening programmes. Identifying some of the sources of heterogeneity between different estimates would help to clarify the issue.
Methods:
The simple case of neuroblastoma-a childhood cancer-screening is used to describe the basic principle of overdiagnosis estimation. The more complicated mechanism of breast cancer overdiagnosis is described based on data from Denmark, taking into account the type of data used, individual or aggregated.
Findings:
The type of data used in overdiagnosis studies has a meaningful effect on the estimation: no study based on individual data provides an estimate higher than 17%, while studies based on aggregated data often provide estimates higher than 40%. This is too systematic to be random. The analysis of two Danish studies, one of each kind, highlights the biases that come with the use of aggregated data and shows how they can lead to overdiagnosis.
Interpretation:
Many estimates of overdiagnosis associated with breast cancer screening programmes are serious overestimations.
More Related Videos
Related Concept Videos
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bias in Epidemiological Studies
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Receiver Operating Characteristic Plot
Cancer Survival Analysis

